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Antimicrobial photodynamic therapy 
Gram-negative E. coli 
A B S T R A C T   
New porphyrin-imidazole derivatives were synthesised by Radziszewski reaction between 2-formyl-5,10,15,20- 
tetraphenylporphyrin 1 and several (hetero)aromatic 1,2-diones, which after cationization afforded promising 
monocationic photosensitizers 3a-d. Singlet oxygen studies have demonstrated that all the cationic porphyrin- 
imidazole conjugates 3a–d were capable to produce cytotoxic species. These photosensitizers were able to 
photoinactivate Eschericha coli and their inactivation profile was improved in the presence of KI.   
1. Introduction 
In the last years, antimicrobial resistance to antibiotics has been 
intensified and it is considered a global threat to human health. In-
fections caused by resistant bacteria which may not be treated with 
antibiotics, are a major warning to public health, with an increased risk 
of morbidity and mortality, and consequently increasing the healthcare 
costs [1,2]. The spread of drug resistant bacteria and the lack of 
adequate antibiotics, requires the urgent development of new and 
effective alternative therapies to antibiotics. 
Antimicrobial Photodynamic Therapy (aPDT) is reported in the 
literature as a promising alternative to antibiotic treatment; in this 
therapeutic approach the combined action of a photosensitizer (PS), 
light and molecular oxygen induces the production of reactive oxygen 
species (ROS), such as singlet oxygen (1O2), triggering microbial inac-
tivation [3,4]. aPDT is a multitarget therapy, acting mainly on the outer 
structures, affecting also nucleic acids.[3,5] Consequently, the devel-
opment of resistance to this therapy is highly improbable[4,6,7]. aPDT 
has already proved its efficiency against Gram-positive and 
Gram-negative bacteria, viruses, fungi and other parasites [8,9]. 
Among the PSs studied within the photoinactivation of 
microorganisms by aPDT, porphyrins are, indubitably, the foremost 
considered class of compounds. Nowadays, several research groups are 
focused in the development of new synthetic approaches for providing 
porphyrin derivatives with proper features for their application in aPDT 
[10–12]. One of the strategies used consists of coupling different moi-
eties with recognized and well-established pharmacological activities. In 
this context, porphyrins can be linked to other biologically active mol-
ecules, aiming to increase their biological efficacy [10,13]. Having in 
mind the already known photodynamic effect of porphyrins and the 
antimicrobial, fungicidal and cytotoxic activity of imidazoles [14], as 
well as their interesting optoelectronic properties giving rise to a wide 
range of applications (e.g. optical chemosensors and nonlinear optical 
(SHG, TPA) chromophores) [15–17], in this work we reported the syn-
thesis and the photodynamic activity of novel cationic 
porphyrin-imidazole derivatives by coupling of 2-formyl-5,10,15,20-tet-
raphenylporphyrin 1 to several 1,2-diones under Radziszewski condi-
tions [14] followed by cationization. The synthesis of other 
porphyrin/imidazole conjugates has been already reported by our group 
and proved to be efficient in the photoinactivation of Escherichia coli 
[18]. As far as we know, most of the functionalizations of the porphyr-
inic macrocycle with imidazole rings were performed at the meso 
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positions or by axial coordination of the imidazole ring to a metal ion at 
the porphyrin core [19–25]. In fact, beyond our work only Nath’s group 
reported the preparation of porphyrin-imidazole derivatives by 
condensation of diamines with the Ni(II) complex of 2-formyl-porphyrin 
1 [18,26]. 
The potentiation of aPDT efficiency with these cationic porphyrin- 
imidazole derivatives by potassium iodide was also accessed [27]. The 
KI reacts with 1O2, affording free iodine (I2/I3  ), hydrogen peroxide 
(H2O2) and iodine radicals (I2⋅-), that are extremely bactericidal [27–34]. 
In fact, several in vitro and in vivo studies have shown the potentiation of 
porphyrins, fullerenes, rose bengal and methylene blue by KI towards 
several microorganisms such as E. coli, Acinetobacter baumannii, 
P. aeruginosa, C. albicans and methicillin-resistant S. aureus [27–29,32, 
35]. 
2. Results and discussion 
2.1. Synthesis and photophysical properties of porphyrin-imidazole 
derivatives 
The synthetic route to access the mono-cationic porphyrin de-
rivatives 3a-d required the preparation of the correspondent neutral 
derivatives 2a-d as outlined in Scheme 1. These intermediates were 
obtained from 2-formyl-5,10,15,20-tetraphenylporphyrin 1 using the 
Radziszewski reaction methodology [14]. The (hetero)aromatic diones 
selected were 1,2-diphenylethane-1,2-dione (Da), 1,2-di(pyridin-2-yl) 
ethane-1,2-dione (Db), 1,2-di(furan-2-yl)ethane-1,2-dione (Dc) and 1, 
10-phenanthroline-5,6-dione (Dd). 
The condensation between the 2-formyl-tetraphenylporphyrin 1 and 
the selected diones D was performed in the presence of ammonium ac-
etate in a refluxing mixture of toluene/acetic acid (5:1) and stopped 
when the TLC control showed the full consumption of the starting ma-
terial 1 (between 1 and 3 h). After workup and purification by column 
chromatography, the corresponding porphyrin-imidazole derivatives 
2a-d were isolated in excellent yields, ranging from 79 to 99% (Table 1). 
The cationization of the imidazole moiety of derivatives 2a-d was 
performed in the presence of an excess of methyl iodide in N,N0-dime-
thylformamide (DMF) for 24 h at 40 �C as outlined in Scheme 2. After 
workup, a TLC monitorization confirmed the conversion of all the 
starting porphyrin-imidazole derivatives 2a-d into more polar com-
pounds. These new derivatives were identified as the mono-cationic 
products 3a-d and were obtained pure in excellent yields (81–97%), 
Scheme 1. Radziszewski reaction between 2-formyl-5,10,15,20-tetraphenylporphyrin 1 and a series of diones D.  
Table 1 
Yields of compounds 2a-d obtained from the Radziszewski reaction between 2- 
formyl-tetraphenylporphyrin 1 and a series of diones Da-d.  
Entry Compound Time (h) Yield (%) 
1 2a 3 79 
2 2b 3 84 
3 2c 1 88 
4 2d 2 99  
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directly from crystallization in CH2Cl2/hexane. 
It is worth to refer that when the cationization/alkylation of com-
pounds 2b and 2d was performed, only the mono-cationic derivatives 
and no products from the additional quaternization of the nitrogens 
from the pyridine and phenanthroline units were detected. 
The structures of both neutral and cationic porphyrin-imidazole 
conjugates prepared were elucidated by NMR, involving 1D (1H and 
13C) and 2D (1H/1H COSY) spectra, HRMS and UV–Vis absorption 
spectroscopy techniques. The 1H NMR spectra of the neutral derivatives 
2a-d clearly show the formation of the imidazole ring and are consistent 
with β-substituted porphyrins, showing a prominent singlet in the range 
from 13.35 ppm to 12.25 ppm due to the resonance of the N–H proton 
from the imidazole ring and the resonance of the corresponding H-3 as a 
singlet at ca. 9.2 ppm or under the multiplet at ca. 8.9 ppm due to the 
resonances of the other β-pyrrolic protons. The resonances of the protons 
from the meso-phenyl groups arise between ca. 8.3 ppm and ca. 7.7 ppm 
and the meta and para protons of one of the phenyl rings are protected by 
the presence of the new imidazole core and the signals of their reso-
nances ranging from 7.26 ppm and ca. 6.60 ppm. 
The most relevant features of the 1H NMR of the mono-cationic de-
rivatives 2a-d are the absence of the signal due to the resonance of the 
imidazole N–H proton and the appearance of a new singlet in the 
aliphatic region ranging from 3.82 ppm and ca. 3.12 ppm due to the 
resonances of the protons from the methyl groups. 
In both neutral (2a-d) and cationic derivatives (3a-d), the 1H NMR 
presents the typical singlet at ca.   2.70 ppm generated by the reso-
nances of the N–H protons at the porphyrinic inner core, confirming 
their free-base form. 
The analysis of the HRMS-ESI(þ) spectra shows the presence of a 
peak with m/z corresponding to the [MþH]þ and [M]þ ions, for the 
neutral derivatives (2a-d) and mono-cationic derivatives (3a-d), 
respectively. 
The electronic spectra of the neutral and mono-cationic derivatives 
were recorded and the ability of the cationic derivatives to produce 
singlet oxygen was measured. For a better evaluation of the influence of 
the different substituents in the photophysical parameters, all the 
studies were performed in the same solvent, namely DMF. 
Fig. 1 shows the absorption spectra of compound 2a in DMF solutions 
at a concentration of 3.0 � 10  6 M recorded at 298 K and of the 
correspondent mono-charged derivative 3a, as a representative example 
for both series of compounds synthesised. 
In general, the electronic spectra show the typical features of a free- 
base meso-tetraarylporphyrin substituted at a β-pyrrolic position, with a 
sharp band centred at ca. 420 nm (Soret band) and four less intense but 
well-defined bands ranging from 518 to 652 nm (Q bands) due to π–π* 
transitions [36–38]. When compared with the corresponding neutral 
derivative, the Soret absorption band of the cationic product is 
red-shifted 3 nm; however, no significant changes were observed in the 
Q bands zone. In both series, the sharp Soret band observed, allowed to 
conclude that the porphyrinic derivatives are not aggregated in DMF 
[38]. 
One of the most relevant features of a photosensitizer is its aptitude 
to generate reactive oxygen species (ROS), namely singlet oxygen (1O2), 
which is strongly related with the efficiency of the photodynamic pro-
cess [39]. 
The capability of the new synthesised mono-charged porphyrin- 
imidazole derivatives to generate 1O2 was quantitatively assessed by 
monitoring the decomposition of 1,3-diphenylisobenzofuran (DPiBF) 
induced by this cytotoxic species generated during their irradiation with 
a red light at 630 � 20 nm [40]. The DPiBF decays obtained after irra-
diating the conjugates 3a-d with the red light at an irradiance of 11.0 
mW cm  2 for 10 min are shown in Fig. 2, and were compared with the 
one induced by 5,10,15,20-tetraphenylporphyrin (TPP), selected as 
reference due to its efficiency to produce oxygen singlet [41]. 
The evaluation of the data obtained with the mono-cationic por-
phyrins 3a-d confirm that they are all capable to induce the decay of the 
DPiBF absorption when irradiated with light. It is worth to refer that the 
absorbance of DPiBF, when irradiated in the absence of a porphyrin 
derivative, remains almost unchanged. 
The most efficient 1O2 producer was derivative 3a with 0.5 time-fold 
higher than the reference TPP. Compound 3b present approximately the 
same ability to generate 1O2 then the reference used in this study. 
Nevertheless, the two remaining derivatives, 3c and 3d, show a note-
worthy lower ability to generate 1O2 when compared with the one 
observed for TPP. These results show that the presence of heteroatoms at 
the substituents into the positions 4 and 5 of the imidazole moiety 
reduce the capability to produce 1O2. Nevertheless, the ability of these 
derivatives to generate 1O2, namely compound 3a, prompted us to 
evaluate their efficacy as photosensitizers in the inactivation of a Gram- 
negative bacteria E. coli. 
Scheme 2. Alkylation/cationization reaction of compounds 2a-d.  
Fig. 1. Absorption spectra of compounds 2a (black line) and 3a (blue line) at a 
concentration of 3.0 � 10  6 M in DMF at 298 K. The inset shows the absorption 
at the Q bands region. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the Web version of this article.) 
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2.2. Photodynamic inactivation of E. coli using cationic porphyrin- 
imidazole derivatives 3a-d as PSs and KI 
The photodynamic efficiency of the cationic porphyrin-imidazole 
derivatives 3a-d was tested against a bioluminescent E. coli strain, 
selected as a bacterial Gram-negative model. Using this bioluminescent 
approach, the aPDT efficacy of each PS can be checked in real-time, 
since the viability of the microorganisms is related with its biolumi-
nescence. In fact, the strong correlation between the colony forming 
units (CFU) and the bioluminescent signal of the bioluminescent E. coli 
used in this work has already been proved and described [42]. 
In order to evaluate the effect of each PS on E. coli photoinactivation 
efficiency, the compounds were tested at different porphyrin concen-
trations (5.0 and 20.0 μM) in the absence and in the presence of 100 mM 
of KI. The concentration of this potentiator agent was chosen in agree-
ment with similar studies, which demonstrated that higher concentra-
tions can promote osmotic stress limiting the application of this 
approach in the clinic area [27]. The photodynamic experiments were 
carried out under irradiation with white light (380–700 nm) at an 
irradiance of 25 mW cm  2 for 90 min. The results obtained are sum-
marized in Fig. 3 and show that the inactivation profile of biolumines-
cent E. coli with cationic porphyrin-imidazole derivatives 3a-d is 
improved in the KI presence (Fig. 3). In all cases, light control, KI control 
and dark controls did not promote a decrease in the bioluminescence 
E. coli signal, showing that the viability of recombinant bioluminescent 
E. coli was not affected by irradiation, by the presence of PS in the dark 
and by the presence of KI. 
Porphyrin-imidazole derivative 3a promoted a decrease of 2.38 log10 
RLU (ANOVA, p < 0.05) and of 3.85 log10 RLU (ANOVA, p < 0.05) in the 
bioluminescence of E. coli at 5 μM and 20 μM, respectively, after 90 min 
of irradiation (Fig. 3 A). For both concentrations of derivative 3a, the 
addition of KI at 100 mM potentiated the photodynamic effect, causing a 
decrease of the E. coli viability till the detection limit of the method 
(decrease of 3.90 log10 RLU) after 75 min and 45 min of irradiation, for 
the combination of porphyrin-imidazole derivative 3a at 5.0 μM þ KI 
and 3a at 20 μM þ KI, respectively. 
In what concerns to the results achieved with porphyrin-imidazole 
3b it was possible to observe that this compound is capable to induce 
a reduction of 1.86 and 3.01 log10 RLU (ANOVA, p < 0.05) in the 
viability of E. coli after 90 min of irradiation, at 5.0 μM and 20 μM, 
respectively (Fig. 3 B). The combination of this PS with KI drastically 
potentiated the photodynamic effect of this PS, since, for both tested 
concentrations inactivation to the detection limit of the method 
(decrease of 4.20 log10 RLU) was reached after 15 min of irradiation. 
Porphyrin-imidazole derivative 3c revealed to be the less efficient PS 
in the photoinactivation of bioluminescent E. coli, causing a decrease of 
0.63 log10 RLU (ANOVA, p < 0.05) in the viability of the bacterium, after 
90 min of irradiation, for both used concentrations (Fig. 3C). However, 
when this compound was used combined with KI the reduction of 
bioluminescent signal begins after 15 min of irradiation and the inac-
tivation to the detection limit of the method (decrease of ca. 4.0 log10 
RLU) was reached after 75 min of irradiation for 5 μM of 3c and after 45 
min of irradiation for 20 μM of 3c. 
The photodynamic profile of porphyrin-imidazole derivative 3d was 
also more accentuated when this compound was combined with KI 
(Fig. 3 D). In this case, the inactivation to the detection limit of the 
method (decrease of 4.0 log10 RLU) was reached after 75 min for com-
bination of derivative 3d at 5.0 μM þ KI and after 30 min of irradiation 
of derivative 3d at 20 μM þ KI. When acting alone, porphyrin-imidazole 
derivative 3d caused a decrease of 1.10 and 1.44 log10 RLU (ANOVA, p 
< 0.05) in the viability of E. coli, after 90 min of irradiation, for 5.0 and 
20 μM, respectively. 
Fig. 2. Photodecomposition of DPiBF (50 μM) in the presence and without 
derivatives 3a-d and TPP at a concentration of 0.5 μM in DMF upon irradiation 
with red light LEDs (654 nm � 20 nm) with an irradiance of 11.0 mW cm  2. 
(For interpretation of the references to colour in this figure legend, the reader is 
referred to the Web version of this article.) 
Fig. 3. Survival of bioluminescent E. coli during aPDT assays in the presence of derivatives 3a (A), 3b (B), 3c (C) and 3d (D) at 5.0 μM and 20 μM alone and combined 
with KI at 100 mM. The values are expressed as the three independent experiments with three replicates; error bars signify the SD; DC - dark control; LC - 
light control. 
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The photodynamic efficiency of each PS was also correlated with the 
single oxygen generation. The capability of 1O2 generation of cationic 
porphyrin-imidazole derivatives 3c and 3d was lower than the one 
achieved for derivatives 3a and 3b, which can justify the poor ability to 
photoinactivate bioluminescent E. coli of these PSs when acting alone. 
Even when combined with KI, these two PSs presented the slower curve 
of photoinactivation, attaining the detection limit latter than the com-
binations of derivatives 3a and 3b with KI. Porphyrin-imidazole de-
rivatives 3a, when acting alone, revealed to be the most promising PS 
achieving higher rates of inactivation of bioluminescent E. coli, which is 
in accordance with the 1O2 generation studies. It is also important to 
highlight the results achieved with combination of derivative 3b þ KI, 
where the inactivation curve suffer a sharp decrease in the first 15 min of 
irradiation. Besides this PS was the second most capable to generate 1O2, 
the combination with KI highly potentiated its photodynamic effect. Due 
to the abrupt decrease in the E. coli survival rate profile, it is possible to 
infer that the mechanism of action of the combination porphyrin- 
imidazole derivative 3b þ KI is probably related to the preferential 
decomposition of the peroxyiodide into free iodine (I2/I3  ) [27,31]. 
Cationic porphyrin-imidazole derivatives 3a and 3b at 20 μM and 
combinations of all cationic porphyrin-imidazole derivatives 3a-d with 
KI can be considered effective antimicrobial agents for E. coli inactiva-
tion, according to the American Society for Microbiology, since it pro-
moted a reduction of at least 3 log10 in the viability of this bacterium 
[43]. 
3. Experimental section 
3.1. General remarks 
The starting porphyrin 1 was prepared following a well-established 
procedure and already reported by our group [44]. Also, the oxygen 
singlet measurements and the biological assays were performed using 
appropriate procedures already described in the literature [18,27]. See 
the supporting information (SI) for a detailed account, as well as, a 
detailed description of all the equipments used in this study. 
3.2. Synthesis 
3.2.1. Synthesis of neutral derivatives 2a-d 
A round bottom flask was charged with 2-formyl-5,10,15,20-tetra-
phenylporphyrin 1 (25 mg, 3.9 � 10  5 mol) dissolved in a toluene/ 
acetic acid 5:1 mixture (1.5 mL), 1.5 equiv. of the appropriate dione and 
ammonium acetate (10 equiv.). Then, the reactional mixture was 
maintained under reflux between 1 and 3 h, until the TLC control 
showed the full consumption of the starting porphyrin. After this period, 
the reaction mixture was allowed to cool to room temperature, diluted 
with CH2Cl2 (5 mL), neutralized with an aqueous NaHCO3 solution and 
extracted with CH2Cl2. The organic layer was dried (Na2SO4) and the 
solvent was evaporated in a rotary evaporator. The residue was purified 
in a silica gel column chromatography and eluted with CH2Cl2 and 
CH2Cl2/MeOH (99:1). The desired products 2a-d were obtained pure 
after crystallization from CH2Cl2/hexane in yields ranging from 79% to 
99%. The porphyrin-imidazole derivatives obtained were fully charac-
terised by adequate spectroscopic techniques. 
3.2.1.1. 2-(4,5-Diphenyl-1H-imidazol-2-yl)-5,10,15,20-tetraphenylpor-
phyrin, 2a. 1H NMR (500 MHz, CDCl3) ¼ δ 9.26 (1H, s, H-3), 8.86 and 
8.84 (2H, AB system, J ¼ 4.9 Hz, H-β), 8.82 (1H, d, J ¼ 4.8 Hz, H-β), 8.80 
(1H, d, J ¼ 4.8 Hz, H-β), 8.78 (1H, d, J ¼ 4.9 Hz, H-β), 8.74 (1H, d, J ¼
4.9 Hz, H-β), 8.34 (1H, s, H-10), 8.23–8.20 (6H, m, H-o-Ph), 8.16–8.15 
(2H, m, H-o-Ph), 7.80–7.76 (11H, m, H-m,p-Ph), 7.36–7.26 (11H, m, H- 
p-Ph, H-20,60, H-30,50 and H-40),   2.62 (2H, s, N–H) ppm. 13C NMR (125 
MHz, CDCl3) ¼ δ 143.6, 142.11, 142.06, 141.7, 141.1, 137.3, 135.0, 
134.61, 134.6, 133.6, 132.4, 131.0, 130.0, 129.9, 129.4, 129.06, 128.9, 
128.8, 128.6, 128.3, 128.0, 127.9, 127.8, 127.7, 127.5, 126.9, 126.74, 
126.71, 126.6, 125.2, 120.9, 120.5, 120.4, 120.3 ppm. MS-ESI(þ): m/z 
833.4 [MþH]þ. HRMS-ESI(þ): m/z calculated to C59H41N6 [MþH]þ
833,3421; found, 833,3387. UV–Vis (DMF): λmax (log ε) 420 (4.37), 518 
(3.29), 552 (2.93), 596 (2.81), 652 (2.76) nm. 
3.2.1.2. 2-(4,5-Di(pyridin-2-yl)-1H-imidazol-2-yl)-5,10,15,20-tetraphe-
nylporphyrin, 2b. 1H NMR (500 MHz, DMSO‑d6) ¼ δ 12.59 (1H, s, N–H), 
8.99–8.73 (7H, m, H-β), 8.63–8.16 (2H, m, H-60), 8.27–8.16 (8H, m, H-o- 
Ph and H-30), 8.03–7.99 (2H, m, H-o-Ph), 7.94–7.74 (11H, m, H-m,p-Ph 
and H-40), 7.30–7.12 (5H, m, H-m,p-Ph and H-50),   2.74 (2H, s, N–H) 
ppm. 13C NMR (125 MHz, DMSO‑d6) ¼ δ 166.1, 156.4, 154.4, 150.3, 
149.8, 148.6, 148.5, 148.2, 143.1, 141.4, 141.3, 140.9, 139.7, 138.2, 
137.7, 136.3, 136.0, 134.9, 134.3, 134.2, 132.7–130.4 (C-β), 129.5, 
128.2, 127.2, 127.1, 126.5, 125.7, 123.3, 122.7, 121.8, 121.6, 120.2, 
120.1, 120.0 ppm. MS-ESI(þ): m/z 835.4 [MþH]þ. HRMS-ESI(þ): m/z 
calculated to C57H39N8 [MþH]þ 835.3292; found, 835.3323. UV–Vis 
(DMF): λmax (log ε) 419 (4.72), 518 (3.44), 552 (3.04), 595 (2.88), 650 
(2.76) nm. 
3.2.1.3. 2-(4,5-Di(furan-2-yl)-1H-imidazol-2-yl)-5,10,15,20-tetraphe-
nylporphyrin, 2c. 1H NMR (500 MHz, DMSO‑d6) ¼ δ 12.26 (1H, s, N–H), 
8.94–8.88 (3H, m, H-β), 8.83–8.74 (4H, m, H-β), 8.27–8.22 (6H, m, H-o- 
Ph), 8.04 (2H, d, J ¼ 7.3 Hz, H-o-Ph), 7.85–7.83 (9H, m, H-m,p-Ph), 7.75 
(2H, d, J ¼ 22.7 Hz, H-50), 7.32 (2H, t, J ¼ 7.3 Hz, H-m-Ph), 7.26 (1H, t, J 
¼ 7.3 Hz, H-p-Ph), 6.78 (1H, d, J ¼ 1.7 Hz, H-30), 6.69 (1H, d, J ¼ 1.7 Hz, 
H-30), 6.64–6.59 (2H, m, H-40),   2.72 (2H, s, N–H) ppm. 13C NMR (125 
MHz, DMSO‑d6) ¼ δ 149.8, 144.94, 143.2, 142.2, 141.5, 141.4, 141.3, 
140.8, 139.5, 135.0, 134.3, 134.1, 132.6–130.4 (C-β), 128.3, 128.2, 
127.2, 127.1, 125.9, 121.5, 120.3, 120.2, 120.0, 119.3, 111.7, 111.3, 
107.3, 106.4 ppm. MS-ESI(þ): m/z 813.3 [MþH]þ. HRMS-ESI(þ): m/z 
calculated to C55H37O2NO6 [MþH]þ 813.2973; found, 813.3018. 
UV–Vis (DMF): λmax (log ε) 420 (4.64), 519 (3.49), 552 (3.13), 595 
(3.00), 651 (2.94) nm. 
3.2.1.4. 2-(1H-imidazo[4,5-f [1,10]phenanthrolin-2-yl)-5,10,15,20- 
tetraphenylporphyrin, 2d. 1H NMR (500 MHz, DMSO‑d6) ¼ δ 13.35 
(1H, s, N–H), 9.09 (1H, s, H-3), 9.06 (2H, dd, J ¼ 4.3 and 1.7 Hz, H-60), 
8.93 (2H, s, H-β), 8.88 (1H, d, J ¼ 7.3 Hz, H-40), 8.56 (1H, d, J ¼ 7.3 Hz, 
H-40), 8.31–8.29 (2H, m, H-o-Ph), 8.27–8.23 (4H, m, H-o-Ph), 8.09 (2H, 
d, J ¼ 7.3 Hz, H-o-Ph), 7.87–7.82 (11H, m, H-m,p-Ph and H-50), 7.01 
(2H, t, J ¼ 7.4 Hz, H-m-Ph), 6.60 (1H, t, J ¼ 7.4 Hz, H-p-Ph),   2.68 (2H, 
s, N–H) ppm. 13C NMR (125 MHz, DMSO‑d6) ¼ δ 147.7, 147.5, 143.3, 
141.3, 141.2, 140.8, 139.7, 135.2, 134.3, 134.2, 133.1–130.4 (C-β), 
129.9, 129.4, 128.4, 128.2, 127.2, 127.1, 126.8, 126.3, 125.5, 124.0, 
123.3, 123.1, 121.4, 120.5, 120.4, 120.2, 119.1 ppm. MS-ESI(þ): m/z 
833.4 [MþH]þ. HRMS-ESI(þ): m/z calculated to C57H37N8 [MþH]þ
833.3136; found, 835.3209. UV–Vis (DMF): λmax (log ε) 420 (4.41), 519 
(3.20), 552 (2.77), 596 (2.62), 651 (2.54) nm. 
3.3. Methylation of porphyrin-imidazole derivatives 2a-d: general 
procedure 
In a sealed tube, the neutral porphyrin-imidazole derivatives 2a- 
d (25.0 mg) dissolved in N,N-dimethylformamide (1 mL) was treated 
with an excess of methyl iodide (60 equiv.) and maintained under stir-
ring, at 40 �C for 12 h. After this period, diethyl ether was added and the 
resulting precipitated was filtered, washed with the same precipitating 
solvent, and finally dissolved in a mixture of CH3OH/CH2Cl2 (1:9). The 
solvent mixture was removed under reduced pressure. Compounds 2a- 
d were isolated after crystallization in a mixture of CH2Cl2/hexane in 
81–97%. The compounds obtained were fully characterised by adequate 
spectroscopic techniques. 
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3.3.1. 2-(4,5-Diphenyl-(1,3-dimethyl)-1H-imidazol-3-ium-2-yl)- 
5,10,15,20-tetraphenylporphyrin iodide, 3a 
1H NMR (500.13 MHz, DMSO‑d6) ¼ δ 9.45 (1H, s, H-3), 9.05 (1H, d, 
J ¼ 4.8 Hz, H-β), 9.01 (1H, d, J ¼ 4.8 Hz, H-β), 8.95 (1H, d, J ¼ 4.8 Hz, H- 
β), 8.80 (1H, d, J ¼ 4.8 Hz, H-β), 8.76 and 8.73 (2H, AB system, J ¼ 4.8 
Hz, H-β), 8.37–8.34 (4H, m, H-o-Ph), 8.25–8.21 (4H, m, H-o-Ph), 
7.91–7.79 (12H, m, H-m,p-Ph), 7.56–7.50 (6H, m, H-20,60and H-40), 
7.41–7.39 (4H, m, H-30,50), 3.48 (6H, s, –CH3),   2.72 (2H, s, N–H) ppm. 
13C NMR (125 MHz, CDCl3) ¼ δ 142.5, 140.79, 140.76, 140.6, 139.3, 
134.8, 134.4, 134.3, 133.4, 130.8, 130.4, 130.1, 129.2, 129.0, 128.5, 
128.4, 127.2, 127.2, 127.1, 125.4, 121.9, 120.8, 120.6, 119.5, 52.8, 
34.3 ppm. MS-ESI(þ): m/z 861.4 [M]þ. HRMS-ESI(þ): m/z calculated 
to C61H45N6þ [M]þ 861.3700 found, 861.3723. UV–Vis (DMF): λmax (log 
ε) 423 (5.40), 520 (4.14), 556 (3.70), 597 (3.57), 654 (3.56) nm. 
3.3.2. 2-(4,5-Di(pyridin-2-yl)-(1,3-dimethyl)-1H-imidazol-3-ium-2-yl)- 
5,10,15,20-tetraphenylporphyrin iodide, 3b 
1H NMR (500.13 MHz, DMSO‑d6) ¼ δ 9.56 (1H, s, H-3), 9.38–931 
(1H, m, H-6"), 9.08–9.02 (2H, m, H-β and H-6"), 8.97 (1H, d, J ¼ 5.0 Hz, 
H-β), 8.88–8.81 (2H, m, H-β), 8.76 and 8.73 (2H, AB system, J ¼ 4.8 Hz, 
H-β), 8.65–8.60 (1H, m, H-3"), 8.49–8.46 (1H, m, H-3"), 8.43–8.35 (3H, 
m, H-o-Ph), 8.30–8.18 (3H, m, H-o-Ph), 8.11–8.04 (2H, m, H-4"), 
7.94–7.80 (11H, m, H-m,p-Ph and H-5"), 7.73–7.67 (2H, m, H-m-Ph), 
7.64–7.58 (1H, m, H-m,p-Ph), 3.82 (3H, s, –CH3), 3.62 (3H, s, –CH3), 
  2.71 (2H, s, N–H) ppm. 13C NMR (125 MHz, CDCl3) ¼ δ 151.1, 150.9, 
150.5, 149.9, 147.0, 146.6, 143.1, 140.8, 140.7, 140.5, 139.6, 139.3, 
138.7, 138.4, 137.7, 135.0, 134.9, 134.4, 134.3, 134.2, 134.1, 133.8, 
133.4, 131.5, 130.1, 129.5, 129.2, 128.6, 128.4, 127.4, 127.3, 127.2, 
126.2, 125.6, 124.8, 124.5, 122.2, 121.7, 121.0, 120.7, 119.3, 47.0, 
35.9 ppm. MS-ESI(þ): m/z 863.4 [M]þ. HRMS-ESI(þ): m/z calculated 
to C59H43N8þ [M]þ. 863.3605; found, 863.3631. UV–Vis (DMF): λmax 
(log ε) 423 (4.53), 520 (3.40), 554 (3.14), 597 (3.11), 653 (3.08) nm. 
3.3.3. 2-(4,5-Di(furan-2-yl)-(1,3-dimethyl)-1H-imidazol-3-ium-2-yl)- 
5,10,15,20-tetraphenylporphyrin iodide, 3c 
1H NMR (500.13 MHz, DMSO‑d6) ¼ δ 9.50 (1H, s, H-3), 9.05 (1H, d, 
J ¼ 5.0 Hz, H-β), 9.01 (1H, d, J ¼ 5.0 Hz, H-β), 8.94 (1H, d, J ¼ 5.0 Hz, H- 
β), 8.79 (1H, d, J ¼ 5.0 Hz, H-β), 8.76 and 8.74 (2H, AB system, J ¼ 4.8 
Hz, H-β), 8.36–8.33 (2H, m, H-o-Ph), 8.29–8.20 (6H, m, H-o-Ph), 8.05 
(2H, d, J ¼ 1.7 Hz, H-50), 7.92–7.81 (9H, m, H-m,p-Ph), 7.67–7.64 (3H, 
m, H-m,p-Ph), 7.03 (2H, d, J ¼ 3.4 Hz, H-30), 6.82 (2H, dd, J ¼ 1.7 and 
3.4 Hz, H-40), 3.59 (6H, s, –CH3),   2.74 (2H, s, N–H) ppm. 13C NMR 
(125 MHz, CDCl3) ¼ δ 163.8, 147.7, 146.2, 144.5, 142.7, 140.8, 140.7, 
140.6, 138.9, 138.152, 134.9, 134.7, 134.3, 133.0, 130.5, 129.0, 128.4, 
127.2, 127.2, 126.9, 123.3, 122.0, 120.8, 120.6, 119.4, 115.0, 112.1, 
54.9, 35.0 ppm. MS-ESI(þ): m/z 841.4 [M]þ. HRMS-ESI(þ): m/z 
calculated to C57H41O2N7þ [M]þ 841.3286; found, 841.3305. UV–Vis 
(DMF): λmax (log ε) 423 (4.48), 520 (3.14), 557 (2.86), 598 (2.67), 653 
(2.66) nm. 
3.3.4. 2-(1,3-dimethyl)-1H-imidazo[4,5-f] [1,10]phenanthrol-3-ium-2- 
yl)-5,10,15,20-tetraphenylporphyrin iodide, 3d 
1H NMR (500.13 MHz, DMSO‑d6) ¼ δ 8.76 (1H, s, H-3), 9.09 (1H, d, 
J ¼ 5.0 Hz, H-β), 9.03 (1H, d, J ¼ 5.0 Hz, H-β), 8.93 (1H, d, J ¼ 5.0 Hz, H- 
β), 8.77–8.73 (3H, m, H-β), 8.40–8.21 (12H, m, H-o-Ph, H-40 and H-60), 
7.97–7.84 (11H, m, H-m,p-Ph and H-50), 7.22–7.12 (2H, m, H-m-Ph), 
6.75–6.46 (1H, m, H-p-Ph), 3.12 (6H, s, –CH3),   2.68 (2H, s, N–H) ppm. 
13C NMR (125 MHz, CDCl3) ¼ δ 156.3, 152.36, 152.35, 151.6, 149.4, 
140.81, 140.75, 140.65, 140.3, 139.8, 139.1, 137.7, 135.2, 134.6, 
134.5, 133.5, 133.2, 131.9–129.3 (C-β), 128.7, 128.63, 128.60, 128.4, 
127.5, 127.4, 126.9, 126.7, 126.6, 126.2, 125.8, 125.3, 124.6, 124.1, 
122.6, 121.7, 121.2, 120.9, 120.4, 119.6, 119.5, 56.3, 38.2 ppm. MS-ESI 
(þ): m/z 861.5 [M]þ. HRMS-ESI(þ): m/z calculated to C59H41N8þ [M]þ
861.3449 found, 861.3480. UV–Vis (DMF): λmax (log ε) 422 (4.38), 518 
(3.13), 552 (2.68), 597 (2.54), 651 (2.46) nm. 
3.4. Antimicrobial Photodynamic Therapy (aPDT) procedure 
E. coli culture was grown overnight and was tenfold diluted in 
phosphate buffered saline (PBS), pH 7.4, to a final bioluminescence of 
108 relative light units (RLU) (corresponding to a concentration of ~108 
CFU mL  1). The obtained suspension was equally distributed in steril-
ized beakers. Then, adequate aliquots of each positively charged de-
rivative (3a-d) to attain the concentration of 5 μM and 20 μM and 100 
mM of KI (total volume was 10 mL per beaker) were added. The samples 
were remained in the dark for 15 min to favour the porphyrin binding to 
E. coli cells. Light control (LC, containing only the E. coli suspension 
exposed to the same light protocol) and dark control (DC, E. coli sus-
pension incubated with each PS at 5 and 20 μM in the absence light) 
were also carried out simultaneously with the aPDT procedure. 
Following the incubation period, the samples and LC were exposed to 
white light irradiation at 2.5 W m  2 under stirring (120 rpm). DC was 
maintained in the dark during the aPDT procedure. The temperature of 
each experiment was controlled and kept at 25 �C. Aliquots of 0.8 mL of 
the samples, LC and DC were collected at time 0 and after 15, 30, 45, 60, 
75 and 90 min of aPDT and the bioluminescence signal was assessed in 
the luminometer. The results were the average of three independent 
experiments with two replicates. 
4. Conclusions 
The results presented herein show that porphyrinic derivatives 
bearing imidazole ring at beta position can be prepared in excellent 
yields through a Radziszewski reaction between 2-formyl-tetraphenyl-
porphyrin and (hetero)aromatic diones. The neutral derivatives can be 
cationized in the presence of methyl iodide affording the correspondent 
mono-charged porphyrin-imidazole derivatives in excellent yields. The 
photochemical properties of the cationic derivatives show their poten-
tial to be used as PSs in photodynamic processes. 
The evaluation of the antimicrobial properties against biolumines-
cent E. coli as a Gram-negative bacterial model showed that these mono- 
charged porphyrin-imidazole derivatives 3a-d efficiently photo-
inactivate this bacterium and the efficiency of the photoinactivation 
profile is highly improved in the presence of KI. 
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